Cargando…

Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients

Background: SPOCK2 is a member of the SPOCK family, a 424-amino acid protein that binds to glycosaminoglycans to form proteoglycans. The purpose of this study was to explore expression profile of SPOCK2, and evaluate prognostic potential and its correlation with immune infiltration in high-grade ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Mi, Sun, Wenbo, Li, Lina, Li, Chunyan, Zhou, Jing, Li, Qian, Duan, Lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554533/ https://www.ncbi.nlm.nih.gov/pubmed/36246613 http://dx.doi.org/10.3389/fgene.2022.878123

Ejemplares similares

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
por: Kieffer, Yann, et al.
Publicado: (2020)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
por: Zhao, Jian, et al.
Publicado: (2021)

SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Zhao, Jinming, et al.
Publicado: (2020)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

Java testing with Spock
por: Kapelonis, Konstantinos
Publicado: (2016)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

High SPOCK1 Expression Is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer
por: Chen, Mei-Ling, et al.
Publicado: (2019)

Spock, 'frito' en segundos
Publicado: (2010)

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
por: Hillman, R Tyler, et al.
Publicado: (2017)

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
por: Lv, Xiaofeng, et al.
Publicado: (2023)

Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas
por: Hachisuga, Toru, et al.
Publicado: (2022)

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
por: Liu, Li-Wei, et al.
Publicado: (2016)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
por: Svoboda, Martin, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021)

Spock, up and running: writing expressive tests in Java and Groovy
por: Fletcher, Rob
Publicado: (2017)

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
por: Pan, Jianbo, et al.
Publicado: (2020)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
por: Song, Honglin, et al.
Publicado: (2021)

Expression signatures of TP53 mutations in serous ovarian cancers
por: Bernardini, Marcus Q, et al.
Publicado: (2010)

Complete Genome of Bacillus thuringiensis Myophage Spock
por: Maroun, Justin W., et al.
Publicado: (2013)

SPOCK1 Promotes the Development of Hepatocellular Carcinoma
por: Váncza, Lóránd, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer
por: Ahn, Hee-Sung, et al.
Publicado: (2020)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer
por: Sun, Xueqi, et al.
Publicado: (2021)

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022)

T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma
por: Kim, Ju-Won, et al.
Publicado: (2023)

Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers
por: Sun, Qian, et al.
Publicado: (2017)

Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer
por: Gong, Wangang, et al.
Publicado: (2020)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis
por: Singh, Prithvi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1kqab0ll51iesqtqqpa9dub5ko